About
NeuraStasis develops StrokeGuard, a non-invasive wearable device that uses electrical stimulation of the trigeminal nerve to increase cerebral blood flow during patient transportation to improve outcomes in ischemic stroke treatment.
Explore NeuraStasis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.